`

Selecta Biosciences

Biotechnology Research

Specialities :
Immunology
Autoimmune
Gene therapy
And enzyme therapy
Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$60.25M
size-icon Size
11 - 50
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About Selecta Biosciences

What does Selecta biosciences do?+

In November 2023, Selecta Biosciences Inc. (NASDAQ: SELB) merged with Cartesian Therapeutics to create a publicly traded company pioneering RNA cell therapy to treat autoimmune disease. The combined company will focus on advancing Cartesians wholly owned pipeline, including Descartes-08, Cartesians clinical-stage lead product candidate being evaluated in patients with myasthenia gravis and other autoimmune diseases. For more information about the company and updates, please visit https://www.cartesiantherapeutics.com/ or follow us on LinkedIn @Cartesian-Therapeutics

What are Selecta biosciences's specialties? +

Immunology,autoimmune,gene therapy,and enzyme therapy

What is Selecta biosciences's industry? +

Selecta biosciences operates in the Biotechnology research industry.

What is Selecta biosciences's revenue? +

Selecta biosciences's revenue is 11m - 100m

What is Selecta biosciences's company size? +

Selecta biosciences has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free